tga bpc-157 approval status New crackdown on illegal peptides could result in criminal penalties. By national health equity reporter Caitlyn Gribbin and national health reporter Stephanie Dalzell, ABC Specialist Reporting Team. #ABCNews #Peptides #Health #TGA The hype around a new

Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For

reconstituted solution refrigerated at 28 C (35.646.4 F) for up to 14 days

My insides were burning that first night, but that slowly subsided

The jump from 5mg to 10mg is significant: 16% to 21.4%

This is the standard used in most of Europe

Inhibiting NNMT increases NAD+ levels in fat cells, Justin Kitchens, FNP-C Functional Medicine Practitioner Board-certified Family Nurse Practitioner specializing in peptide therapy, hormone optimization, medical weight loss, and regenerative wellness